Noticias de Eulerpool Denali Therapeutics

Denali Therapeutics Noticias de Acciones

Denali Therapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Denali Therapeutics.

• 10 de enero ·

  SeekingAlpha
  NervGen In Spotlight As It Approaches Clinical Proof Of Concept Readout For Spinal Cord Regeneration
• 9 de enero ·

  Yahoo
  DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation
• 9 de enero ·

  SeekingAlpha
  Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains
• 8 de enero ·

  Yahoo
  Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)
• 8 de enero ·

  Yahoo
  Denali Therapeutics price target lowered to $32 from $35 at BTIG
• 7 de enero ·

  Yahoo
  These Stocks Moved the Most Today: Nvidia, Micron, Aurora Innovation, Tesla, Carvana, Moderna, Palantir, and More
• 7 de enero ·

  Yahoo
  Denali's ALS Study Fails to Meet Primary and Secondary Endpoints
• 7 de enero ·

  Yahoo
  Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
• 7 de enero ·

  Yahoo
  Denali Reverses Its Fortunes With 'Too Early' Miss In ALS Treatment
• 7 de enero ·

  Yahoo
  Denali Therapeutics’ ALS therapy fails to meet primary endpoint in Phase II/III trial